From: High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
 |  | LG patient samples (n = 129) | HG patient samples (n = 164) | ||||
---|---|---|---|---|---|---|---|
 |  | Cervical (n = 44) | Anal (n = 41) | Oro-pharyngeal (n = 44) | Cervical (n = 56) | Anal (n = 52) | Oro-pharyngeal (n = 56) |
 | 16 (p = 0.41) | 20 (45.5%) | 24 (58.5%) | 22 (50.0%) | 33 (58.9%) | 28 (53.8%) | 31 (55.4%) |
 | 31 (p = 0.49) | 10 (22.7%) | 10 (24.4%) | 13 (29.5%) | 14 (25.0%) | 10 (19.2%) | 12 (21.4%) |
High-risk (HR) & probable HR (PHR) | 33 (p = 0.55) | 8 (18.2%) | 9 (22.0%) | 10 (22.7%) | 9 (16.1%) | 6 (11.5%) | 14 (25.0%) |
 | 53 (p = 0.083) | 6 (13.6%) | 10 (24.4%) | 5 (11.4%) | 5 (8.9%) | 12 (23.1%) | 3 (5.4%) |
 | 59 (p = 0.26) | 6 (13.6%) | 9 (22.0%) | 9 (20.5%) | 3 (5.4%) | 7 (13.5%) | 6 (10.7%) |
 | 45 (p = 0.40) | 7 (15.9%) | 11 (26.8%) | 7 (15.9%) | 6 (10.7%) | 4 (7.7%) | 4 (7.1%) |
 | 56 (p = 0.0004) | 5 (11.4%) | 7* (17.1%) | 7# (15.9%) | 2 (3.6%) | 1 (1.9%) | 2 (3.6%) |
 | 18 (p = 0.068) | 1 (2.3%) | 2 (4.9%) | 2 (4.5%) | 6 (10.7%) | 5 (9.6%) | 5 (8.9%) |
 | 66 (p = 0.0059) | 3 (6.8%) | 5 (12.2%) | 4 (9.1%) | 1 (1.8%) | 1 (1.9%) | 1 (1.8%) |
 | Othersa | 22 | 23 | 17 | 31 | 19 | 23 |
Low-risk (LR) b | 18 | 16 | 10 | 12 | 15 | 8 | |
Undetermined-risk (UDR) c | 10 | 10 | 8 | 7 | 9 | 3 | |
Total | 116 | 136 | 114 | 129 | 117 | 112 |